Franciscan Health Michigan City joins nationwide outpatient study to test medications’ efficacy against mild-to-moderate COVID-19
Franciscan Health Michigan City has joined a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are already approved by the U.S. Food and Drug Administration with known safety records, which are being tested for a new purpose. Infectious disease physician Dafer Al-Haddadin, MD, serves as principal investigator for the research site at Franciscan Health Michigan City. “We are trying to be part of the future solution for COVID-19 and are excited to provide our community the benefit of such clinical trials. We ask everyone to join and help spread the
